Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) shares traded down 2.4% during mid-day trading on Thursday . The company traded as low as $5.67 and last traded at $5.68. 13,724 shares were traded during trading, an increase of 49% from the average session volume of 9,188 shares. The stock had previously closed at $5.81.
Elekta AB (publ) Trading Up 1.3 %
The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.74 and a current ratio of 0.99. The firm has a market cap of $2.21 billion, a P/E ratio of 23.00 and a beta of 1.23. The firm has a 50 day simple moving average of $6.07 and a 200 day simple moving average of $6.36.
Elekta AB (publ) Company Profile
(
Get Free Report)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
See Also
Before you consider Elekta AB (publ), you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta AB (publ) wasn't on the list.
While Elekta AB (publ) currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
